All Stories

  1. A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy

    Article • OncoTargets and Therapy, December 2015, Dove Medical Press

    Dr Mark Abramovitz, Dr Brian R Leyland-Jones